Metsera

interesting, once-monthly shot without titration. could be convenient for patients but better hope the side effects profile is tolerable, otherwise you're living with them for a month.

I also saw this: Metsera isn’t putting all its eggs in one basket. The company is also advancing MET-233i, an ultra-long-acting injectable amylin analog designed for combination therapy with MET-097i.

so they're doing their version of cagrilintide to combine with MET-097i, so a once-monthly version of CagriSema, or more like CagriTirz or CagriMariTide really. hope they can keep the alzheimers at bay, that could be a powerful combination
 

Trending content

Forum statistics

Threads
2,107
Messages
36,038
Members
3,766
Latest member
Akieye
Back
Top